Renee Aguiar-Lucander
CEO
Calliditas Therapeutics
Khatereh Ahmadi
Head of Search and Evaluation Team, European BD&L Hub
MSD
Mehdi Ainouche
Principal
Jeito
Michael Altorfer
CEO
Swiss Biotech Association
Madeleine Armstrong
News Editor
Evaluate
Simon Basham
Head of Cyber & TMT Broking UK
WTW
Maina Bhaman
Partner
Sofinnova Partners
Robin Bhattacherjee
CEO
Actimed Therapeutics
Bernd Boidol
CEO
Proxygen
Jasper Bos
General Partner, Forbion
CEO, Forbion European Acquisition
Viola Bronsema
CEO
BIO Deutschland
Roel Bulthuis
Managing Director
INKEF Capital
Matt Cardinal
VP Strategy & Program Leadership
Halloran
Björn Carlsson
Principal Consultant & Advisory Board Member
NDA Group
John Cassidy
Investment Director Life Sciences & HealthTech
Softbank Vision Fund
Chris Chamberlain
Executive Director Experimental Medicine
AstraZeneca
Jean-Philippe Combal
CEO
Vivet Therapeutics
Yuehua Cong
Executive Director, Head of Europe
Simcere Pharmaceutical Group
Jette Cowan
Head Of Commercial – Pharmaceuticals
RSSL
Sarah Cowlishaw
Partner
Covington & Burling
Ian Coyne
Executive Director Global Information & Intelligence
Coulter Partners
David Crome
Managing Director Compliance UK
ProPharma Group
Maria Dahl
COO and Head of Europe
Innovent Bio
Victoria Darbyshire
Equity Analyst
J.P. Morgan
Nach Dave
Vice President Development Strategy
Premier Research
John Dawson
Director
Oxford BioMedica
Lucas de Breed
Founder
August
Ros Deegan
CEO
OMass Therapeutics
Graham Defries
Partner
Goodwin
Christian Dillon
CSO
Phoremost
Guy Dingley
Partner
Covington & Burling
Mark Dorff
Partner
Brown Rudnick
Angela Drew
Director Regulatory Strategy
Premier Consulting
Abie Ekangaki
Vice President, Statistical Consulting
Premier Research
Beth Fordham-Meier
VP, Business Development, BioConsulting
Lumanity
Jason Foster
CEO
Ori Biotech
Hayley French
Investor
Vesalius Biocapital Partners
Lala Gregorek
Healthcare Analyst
Trinity Delta
Franc Gregori
Analyst
Trinity Delta
Andrew Hack
Managing Director
Bain Capital Life Sciences
James Halstead
Partner
Covington & Burling
Sofia Håkansson Buch
VP Cell Therapy CMC
Novo Nordisk
Alex Hamilton
Partner
Syncona
Deborah Harland
Venture Partner
SROne
Steven Harris
Chairman
CS Pharmaceuticals
Andrew Harrow
Partner
Goodwin
Bill Haynes
Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Brian Heaphy
SVP, Corporate Development
BMS
Andrew Hill
Product Innovation Lead
WTW
Regina Hodits
Managing Partner
Wellington Partners
Ben Hohn
Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead
ZS Associates
Asaf Homossany
Senior Managing Director - EMEA
Nasdaq
Anne Horgan
Partner
Cambridge Innovation Capital
Patrick Hughes
Director, Advisory Services EMEA
Nasdaq
Sofia Ioannidou
Partner
Andera Partners
Catherine Isted
CFO
ReNeuron
Pierre-Louis Joffrin
CDO
Mogrify
Fredrik Johansson
CFO
Calliditas Therapeutics
Markus Kalousek
Global Head Search & Evaluation
Novartis
Tahera Kan
VP Transactions, Johnson & Johnson Innovation EMEA
Johnson & Johnson
Maya Khurana
Health and Life Sciences Director
Oliver Wyman
Dima Kuzmin
Managing Director
4BIO Capital
Werner Lanthaler
CEO
Evotec
Stephanie Léouzon
Partner
Torreya
Marta Helena Lesko
Head of BD Enabling Technologies
Merck KGaA
Wen Hwa Lee (He/him)
CEO and Chief Scientist
Action Against AMD
Peter Llewellyn-Davies
CEO
invIOs
Tim Luker
VP Venture Science, Corporate BD
Eli Lilly
Nanna Lüneborg
General Partner
Forbion
Priya Mande
CEO
PsiOxus Therapeutics
Guy Martin
Deputy Editor
Pharma Letter
Anton Mat
Director of Business Development
ISA Pharmaceuticals
Giuseppe Mazza
CEO
Engitix Therapeutics
Robbie McLaren
Partner and Vice Chair of the Global Life Sciences Practice
Latham & Watkins
Anita Meiklejohn
Principal
Fish & Richardson
Jason Mellad
CEO
Start Codon
Lisa Melton
Senior News Editor
Nature Biotechnology
Piers Morgan
CFO
Cellcentric
Tim Morris
COO/CFO
Humanigen
Rachel Moss
Partner
McKinsey
Jukka Muhonen
Global BD & Alliances
Orion Pharma
Matthias Müllenbeck
, SVP, Head Global BD & Alliance Management
Merck KGaA
Tej Panesar
Investment Director, Life Sciences
British Patient Capital
Francis Pang
VP Global Market Access
Orchard Therapeutics
Pierluigi Paracchi
CEO & Co-founder
Genenta Science
Nick Pattinson
Head of Product
Automata
Morag Peberdy
Of Counsel
Covington & Burling
Elisa Petris
Partner
Syncona
Martin Pfister
Principal
HTGF
Jim Polson
Managing Director
FTI Consulting
Rebecca Pope (she/her)
UK Digital & Data Science Innovation Lead
Roche Products
Steven Powell
CEO
eTheRNA immunotherapies
Cody Powers
Principal - Portfolio & Pipeline
ZS Associates
Marc Ramis Castelltort
Venture Partner
Chasing Science
Tara Raveendran
Head of Healthcare & Life Sciences Research
Polar Capital
Brad Robling
VP, Lilly Ventures, Corporate BD
Eli Lilly
Andrew Roddam
CEO
Our Future Health
Kieran Rooney
VP, Strategic Alliances and Licensing
Amryt Pharma
Chris Rowe
Innovation Lead
Innovate UK
Igor Rudychev
VP Enterprise Analytics
Horizon Therapeutics
Arthur Sands
CEO
Nurix Inc.
Ed Saltzman
Head, Biotech Strategy
Lumanity
Isabella Schidrich
Senior Managing Director
Nasdaq
Sara Secall
Partner
Inveready
Graziano Seghezzi
Managing Partner
Sofinnova
Nigel Sheail
Global Head of M&A and BD&L
Novartis
Tom Shepherd
CEO
Captor Therapeutics
João Siffert
CEO & President
Design Therapeutics
Stephanie Sirota
Partner and CBO
RTW Investments
Ulrica Slåne Bjerke
CIO
Arctic Aurora LifeScience
Rhoda Steel
Head of Community Impact
Johnson & Johnson UK
Johan Strömquist
CEO
NDA Group
Anette Steenberg
CEO
Medicon Valley Alliance
Nicki Thompson
CEO
Amphista Therapeutics
Andrew Udell
President, North America
Calliditas Therapeutics
Erik van den Berg
CEO
AM Pharma
Sally van Kooten
VP Commercial Strategy
KalVista Pharmaceuticals
Edward van Wezel
Managing Partner
BGV
Bonnie Van Wilgenburg
Principal
Monograph Capital Partners
Valerie Vanhooren
CEO & Co-Founder
ONA Therapeutics
Pnina Weitz
Global Head of VC Business Development & Relationship Management
Lonza
Nicklas Westerholm
CEO
Egetis Therapeutics
Anna Williamson
Executive Director
Roche Pharma Partnering
Donald Xu
Managing Director
Lynx Capital
Alexandra Zemp
Partner
McKinsey
Klaas Zuideveld
CEO
Versameb
.jpeg)
%2c%20UK%20Digital%20%26%20Data%20Science%20Innovation%20Lead%2c%20Roche.jpeg)
